Source:http://linkedlifedata.com/resource/pubmed/id/19239900
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-2-25
|
pubmed:abstractText |
The Notch2 ligand DL1 is required for marginal zone B cell development. In this issue of Immunity, Tan et al. (2009) show that modification of Notch2 by Fringe enzymes is critical to maturing B cells for accessing DL1 on vascular endothelial cells.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1097-4180
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
20
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
175-7
|
pubmed:dateRevised |
2009-6-8
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
Instructing B cell fates on the fringe.
|
pubmed:affiliation |
Department of Pathology and Laboratory Medicine, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6082, USA.
|
pubmed:publicationType |
Journal Article,
Comment
|